Worm Generator: A System for High-Throughput in Vivo Screening

被引:7
|
作者
Yang, Anqi [1 ]
Lin, Xiang [1 ]
Liu, Zijian [1 ]
Duan, Xin [1 ]
Yuan, Yurou [1 ]
Zhang, Jiaxuan [1 ]
Liang, Qilin [1 ]
Ji, Xianglin [2 ]
Sun, Nannan [3 ]
Yu, Huajun [3 ]
He, Weiwei [4 ]
Zhu, Lili [4 ]
Xu, Bingzhe [1 ]
Lin, Xudong [1 ]
机构
[1] Sun Yat sen Univ, Sch Biomed Engn, Guangdong Prov Key Lab Sensor Technol & Biomed Ins, Shenzhen Campus, Shenzhen 518000, Peoples R China
[2] City Univ Hong Kong, Dept Biomed Engn, Kowloon, Hong Kong 999077, Peoples R China
[3] Guangdong Med Univ, Dept Biochem & Mol Biol, Zhanjiang 524023, Peoples R China
[4] East China Univ Sci & Technol, Sch Pharm, Shanghai 200237, Peoples R China
基金
中国国家自然科学基金;
关键词
triboelectric nanogenerator; microfluidics; Caenorhabditis elegans; high-throughput; drug screening; CAENORHABDITIS-ELEGANS; BEHAVIORAL-ANALYSIS; SMALL MOLECULES; IDENTIFICATION; CAFFEINE;
D O I
10.1021/acs.nanolett.2c04456
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Large-scale screening of molecules in organisms requires high-throughput and cost-effective evaluating tools during preclinical development. Here, a novel in vivo screening strategy combining hierarchically structured biohybrid triboelectric nano-generators (HB-TENGs) arrays with computational bioinformatics analysis for high-throughput pharmacological evaluation using Caenorhabditis elegans is described. Unlike the traditional methods for behavioral monitoring of the animals, which are laborious and costly, HB-TENGs with micropillars are designed to efficiently convert animals' behaviors into friction deformation and result in a contact-separation motion between two triboelectric layers to generate electrical outputs. The triboelectric signals are recorded and extracted to various bioinformation for each screened compound. Moreover, the information-rich electrical readouts are successfully demonstrated to be sufficient to predict a drug's identity by multiple-Gaussian-kernels-based machine learning methods. This proposed strategy can be readily applied to various fields and is especially useful in in vivo explorations to accelerate the identification of novel therapeutics.
引用
收藏
页码:1280 / 1288
页数:9
相关论文
共 50 条
  • [31] High-throughput ADE screening
    Kretz, O
    Probst, A
    PHARMACOKINETIC OPTIMIZATION IN DRUG RESEARCH: BIOLOGICAL, PHYSICOCHEMICAL, AND COMPUTATIONAL STRATEGIES, 2001, : 199 - 215
  • [33] High-throughput screening challenges
    不详
    GENETIC ENGINEERING & BIOTECHNOLOGY NEWS, 2008, 28 (14): : 26 - 27
  • [34] High-throughput screening for polymorphism
    Hilfiker, R
    Berghausen, J
    Blatter, F
    De Paul, SM
    Szelagiewicz, M
    Von Raumer, M
    CHIMICA OGGI-CHEMISTRY TODAY, 2003, 21 (09) : 75 - +
  • [35] Optogenetic high-throughput screening
    Brenker, Kathrin
    Jakob, Annik
    Koebele, Luis
    EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS, 2021, 50 (SUPPL 1): : 139 - 139
  • [36] The future of high-throughput screening
    Mayr, Lorenz M.
    Fuerst, Peter
    JOURNAL OF BIOMOLECULAR SCREENING, 2008, 13 (06) : 443 - 448
  • [37] High-throughput hybridoma screening
    Sawyer A.
    Hall D.
    Genetic Engineering and Biotechnology News, 2011, 31 (05): : 28 - 32
  • [38] High-throughput virtual screening
    Shuzo Hirata
    Katsuyuki Shizu
    Nature Materials, 2016, 15 : 1056 - 1057
  • [39] High-throughput enhancer screening
    Hannah Stower
    Nature Reviews Genetics, 2012, 13 (4) : 223 - 223
  • [40] Whither high-throughput screening?
    Burbaum, JJ
    DRUG DISCOVERY TODAY, 2000, : 1 - 2